Keyphrases
Placebo-controlled
100%
Randomized Double-blind
100%
Proof of Concept Study
100%
Complex Posttraumatic Stress Disorder (CPTSD)
100%
Neurokinin-1 Receptor Antagonist
100%
Clinician-Administered PTSD Scale
100%
Placebo
83%
Cerebrospinal Fluid
50%
NK1R Antagonist
33%
Stress Model
16%
Adverse Effects
16%
Adverse Events
16%
Drug Effects
16%
No Significant Difference
16%
Randomized Placebo-controlled Trial
16%
Tolerability
16%
Short-term Treatment
16%
Response Rate
16%
Hyperarousal Symptoms
16%
Change from Baseline
16%
Fixed-dose Combination
16%
Substance P
16%
Receptor System
16%
Symptom Cluster
16%
Combat-related PTSD
16%
Placebo Lead-in
16%
Neurokinin-1 Receptor (NK1R)
16%
Medicine and Dentistry
Placebo
100%
Posttraumatic Stress Disorder
100%
Neurokinin 1 Receptor Antagonist
100%
Vofopitant
58%
Clinician
50%
Cerebrospinal Fluid
25%
Adverse Event
16%
Neutron Capture Therapy
16%
Drug Therapy
8%
Outpatient
8%
Receptor
8%
Short Course Therapy
8%
Fight-or-Flight Response
8%
Neurokinin 1 Receptor
8%
Substance P
8%
Neuroscience
Posttraumatic Stress Disorder
100%
Placebo
100%
Receptor Antagonist
100%
Neurokinin 1 Receptor
100%
Adverse Effect
8%
Fight-or-Flight Response
8%
Substance P
8%
Receptor
8%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Posttraumatic Stress Disorder
100%
Neurokinin 1 Receptor Antagonist
100%
Vofopitant
58%
Adverse Event
16%
Tolerability
8%
Receptor
8%
Substance P
8%
Neurokinin 1 Receptor
8%